- AmerisourceBergen (NYSE:ABC) upgraded to Buy with a $105 (18% upside) price target by Goldman Sachs.
- Biohaven Pharmaceutical Holding (NYSE:BHVN) initiated with Buy rating by Canaccord Genuity.
- Restoration Robotics (NASDAQ:HAIR) initiated with Buy rating and $7.50 (39% upside) price target by Roth Capital.
- IQVIA Holdings (NYSE:IQV) initiated with Neutral rating and $112 (10% upside) price target by MUFG.
- Intra-Cellular Therapies (NASDAQ:ITCI) initiated with Buy rating and $31 (108% upside) price target by Canaccord.
- PRA Health Sciences (NASDAQ:PRAH) initiated with Overweight rating and $102 (15% upside) price target by MUFG. Shares up a fraction premarket.
- Rigel Pharmaceuticals (NASDAQ:RIGL) initiated with Overweight rating and $6 (68% upside) price target by Cantor Fitzgerald. Shares up 4% premarket.
- Express Scripts (NASDAQ:ESRX) upgraded to Outperform with an $81 (17% upside) price target by Baird. Shares are up a fraction premarket.
- Teva Pharmaceutical Industries (NYSE:TEVA) upgraded to Buy with a $20 (16% upside) price target by Goldman Sachs. Shares up 4% premarket on robust volume.
- Cardiovascular Systems (NASDAQ:CSII) downgraded to Hold by Needham.
- Amgen (NASDAQ:AMGN) removed from Conviction Buy list at Goldman.
- BioMarin Pharmaceutical (NASDAQ:BMRN) and Alnylam Pharmaceuticals (NASDAQ:ALNY) added to Conviction Buy list at Goldman. AMGN up 2% premarket. ALNY up 5% premarket.